LivaNova PLC (LIVN)
NASDAQ: LIVN · Real-Time Price · USD
79.97
+0.56 (0.71%)
At close: Aug 26, 2026, 4:00 PM EDT
79.97
0.00 (0.00%)
After-hours: Aug 26, 2026, 4:38 PM EDT

LivaNova Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
1,4721,3881,2531,1541,0221,035
Revenue Growth
12.39%10.74%8.66%12.89%-1.31%10.82%
Gross Profit
1,005944.07854.78768.42707.23705.99
Operating Income
215.25211.39165.3969.5581.5648.9
Net Income
188.55-242.4763.2317.55-86.25-135.82
Earnings Per Share
3.40-4.451.160.32-1.61-2.68
EPS Growth
--262.50%---

Revenue by Segment

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cardiopulmonary
840.02785.39683.51604.11514.2482.98
Neuromodulation
620.98592.81554.22519.71476.99456.17
Other
10.519.8615.729.7230.6140.76
Total
1,4721,3881,2531,1541,0221,035

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
516.62635.55428.86266.5215.51207.99
Total Debt
351.95433.77676.77640.4580.43286.7
Net Cash (Debt)
164.67201.78-247.92-373.9-364.92-78.71
Net Cash Growth
48.54%-----
Net Cash Per Share
2.973.70-4.54-6.90-6.82-1.55

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
249.26254.34183.0474.9169.92102.54
Capital Expenditures
-100.95-81.05-47.11-34.98-26.52-25.48
Free Cash Flow
148.31173.29135.9339.9343.477.07
Free Cash Flow Growth
-8.51%27.48%240.40%-8.00%-43.68%-

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
68.27%68.01%68.19%66.61%69.21%68.19%
Operating Margin
14.63%15.23%13.20%6.03%7.98%4.72%
Pretax Margin
7.24%-15.91%7.04%-7.05%-7.36%-12.04%
Profit Margin
12.81%-17.47%5.04%1.52%-8.44%-13.12%
FCF Margin
10.08%12.48%10.85%3.46%4.25%7.44%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
23.34-39.77158.85--
Forward PE
17.7815.6213.2817.4422.5837.01
P/FCF Ratio
29.5619.3918.5069.8068.4960.38
PS Ratio
2.982.422.012.422.914.50